Crossmark

Supplement to “Effect and Safety of Hydroxysafflor Yellow A for Injection in Patients with Acute Ischemic Stroke of Blood Stasis Syndrome: A Phase II, Multicenter, Randomized, Double-Blind, Multiple-Dose, Active-Controlled Clinical Trial”

Crossref DOI link: https://doi.org/10.1007/s11655-024-3911-5

Published Online: 2024-05-16

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Zhou, Zi-yi

Wang, Xia

Gu, Shan-ye

Cai, Ye-feng
License Information

Text and Data Mining valid from 2024-05-16

Version of Record valid from 2024-05-16
More Information

Article History

Accepted: 5 December 2023

First Online: 16 May 2024

Conflict of Interest

: This work was supported by Guangzhou Youcare Biopharmaceutical Co. Ltd., China. The funding body was not involved in the study design. The authors declare that there is no conflict of interest regarding the publication of this paper, and we have no financial or personal relationships with any organizations, products, or services that can inappropriately influence our work.

Document is current

Any future updates will be listed below